Back to search

Article

Modulation of novel drug targets in neurotransmitter signalling to eradicate leukaemic stem cells in chronic myeloid leukaemia

2019-01-01

Abstract excerpt

The most significant obstacle in developing a cure for chronic myeloid leukaemia (CML) is the existence of TKI-insensitive leukaemic stem cells (LSCs) in patients with residual disease. Previous transcriptomics analysis pointed to neurotransmitter pathways as being active in LSC and normal haematopoietic stem cells (HSCs), but significantly deregulated between them. It was therefore hypothesised that these pathway...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
693d029f-4326-5d5b-956e-079a2ac20e5a
DOI
10.5525/gla.thesis.79052
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modulation of novel drug targets in neurotransmitter signalling to eradicate leukaemic stem cells in chronic myeloid leukaemiaDOI 10.5525/gla.thesis.79052
Select a neighboring publication to make it the new centre.